We use our proficiency in brain sciences research to fight disease and create new materials and processes. Technology transfer allows us to maximise the commercial potential of our discoveries and transform lives.
AstronauTx is a biotech company that builds on research from the Alzheimer's Research UK UCL Drug Discovery Institute (DDI). Launched in 2019, it has attracted £7.5 million of investment.
Research originating from the Department of Genetics at the UCL Institute of Ophthalmology hopes to treat devastating eye diseases that cause blindness.
Close
